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Abstract
Background: Chronic inflammation activated by macrophage innate pathogen recognition receptors such as TLR4
can lead to a range of inflammatory diseases, including atherosclerosis, Crohn’s disease, arthritis and cancer. Unlike
many microbes, the kinetoplastid protozoan pathogen Leishmania has been shown to avoid and even actively
suppress host inflammatory cytokine responses, such as LPS-induced IL-12 production. The nature and scope of
Leishmania-mediated inflammatory cytokine suppression, however, is not well characterized. Advancing our
knowledge of such microbe-mediated cytokine suppression may provide new avenues for therapeutic intervention
in inflammatory disease.
Methods: We explored the kinetics of a range of cytokine and chemokine responses in primary murine
macrophages stimulated with LPS in the presence versus absence of two clinically distinct species of Leishmania
using sensitive multiplex cytokine analyses. To confirm that these effects were parasite-specific, we compared the
effects of Leishmania uptake on LPS-induced cytokine expression with uptake of inert latex beads.
Results: Whilst Leishmania uptake alone did not induce significant levels of any cytokine analysed in this study,
Leishmania uptake in the presence of LPS caused parasite-specific suppression of certain LPS-induced pro-
inflammatory cytokines, including IL-12, IL-17 and IL-6. Interestingly, L. amazonensis was generally more suppressive
than L. major. We also found that other LPS-induced proinflammatory cytokines, such as IL-1a, TNF-a and the
chemokines MIP-1a and MCP-1 and also the anti-inflammatory cytokine IL-10, were augmented during Leishmania
uptake, in a parasite-specific manner.
Conclusions: During uptake by macrophages, Leishmania evades the activation of a broad range of cytokines and
chemokines. Further, in the presence of a strong inflammatory stimulus, Leishmania suppresses certain
proinflammatory cytokine responses in a parasite-specific manner, however it augments the production of other
proinflammatory cytokines. Our findings highlight the complexity of inflammatory cytokine signalling regulation in
the context of the macrophage and Leishmania interaction and confirm the utility of the Leishmania/macrophage
infection model as an experimental system for further studies of inflammatory regulation. Such studies may
advance the development of therapies against inflammatory disease.
Background
Inflammatory diseases such as atherosclerosis are often
caused by chronic inflammation and encompass a large
spectrum of diseases, including atherosclerosis, Crohn’s
disease, arthritis and cancer [1-6]. Persistence of, or
repeated exposure to certain microbial pathogens, leads
to chronically elevated levels of several etiologic inflam-
matory mediators, including the cytokines IL-12, tumor
necrosis factor alpha (TNF-a), interferon-gamma (IFN-
g), IL-6 and IL-17 [1,7], that are considered to contri-
bute to the onset of inflammatory diseases. Production
of these cytokines typically ensues via host cell signalling
cascades following the engagement of innate pathogen-
associated molecular pattern (PAMP) receptors includ-
ing the Toll-like receptors (TLRs) expressed primarily
by cells of the innate immune compartment, by
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charide (LPS) [8]. Importantly, recent studies with gene-
knockout mice and also human TLR polymorphisms
have confirmed that TLR signaling in response to patho-
gen contact can also contribute to the development of
atherosclerosis [9,10]. The mechanisms that underlie
inflammatory cytokine induction following engagement
of the TLR receptors have been well studied for a num-
ber of cytokines and commonly result in nuclear trans-
location of nuclear factor kappa-light-chain-enhancer of
activated B cells (NF-B), a Rel-family transcription fac-
tor, followed by its binding to DNA sequences asso-
ciated with the promoters of their target genes such as
IL-12 [11]. In addition to NF-B activation, TLR signal-
ing may also activate mitogen activated protein (MAP)
kinase pathways that lead to activation of the transcrip-
tion factor activating protein 1 (AP-1) and interferon
regulatory factor (IRF) signalling [1].
In contrast, whilst macrophage IL-17 production has
been demonstrated to be important in allergic inflam-
mation [7], pathways that culminate in the regulation of
this proinflammatory cytokine in macrophages, however,
have not yet been characterized.
Unlike most microbial pathogens, insect stages (pro-
mastigotes) of the protozoan trypanosomatid parasite
Leishmania enter macrophage host cells in a way that
eludes immediate “classical” proinflammatory activation.
Furthermore, a number of studies have shown that
upon LPS stimulation of macrophages, IL-12 is actively
suppressed by Leishmania [12,13]. Leishmania major-
infected C57/BL6 mice, also show an initial “silent”
phase of parasite replication that persists in the dermis
for up to 5 weeks [14] prior to disease resolution, indi-
cating parasite-mediated immune evasion occurs in vivo.
Experimental infections with L. amazonensis also show
early impairment of inflammatory responses [15].
Importantly, microarray experiments also showed that
infection of the human monocyte line, THP-1, with
Leishmania suppressed the IFNg-induced expression of
many host genes [16].
Cameron et al., [12] showed that the suppression of
LPS-induced IL-12 by L. mexicana correlated with
degradation of the innate immune signaling MAP
kinases JNK and ERK, and also components of the NF-
B signaling pathway, indicating that Leishmania may
promote a generalized abrogation of the inflammatory
response.
Additional mechanisms that have been proposed for
Leishmania’s ability to suppress inflammatory activation
include the engagement of suppression-associated
macrophage surface receptors such as complement
receptor 3 (CR3) and the elaboration of suppressive
cytokines such as IL-10 [17,18]. Indeed, studies of
macrophages from CR3-deficient mice have confirmed
that CR3 engagement is involved in IL-12 suppression
during Leishmania i n f e c t i o ne v e ni nt h ep r e s e n c eo f
IFN-g stimulation [17,19].
Although some progress toward understanding how
Leishmania suppresses macrophage inflammatory
responses has been made, our knowledge of the extent
to which Leishmania modulates macrophage cytokine
responses and the underlying molecular mechanisms
involved, remains limited.
To further our understanding of host inflammatory
responses modulated by Leishmania,w eh a v ee x p l o r e d
the inflammation-suppressive effects of both L. major
and L. amazonensis in the context of macrophage infec-
tion during TLR4 stimulation, upon a broader range of
cytokines than previously studied. These parasites repre-
sent two related but distinct microbes responsible for
clinically distinct forms of leishmaniasis. Specifically, we
studied the modulatory effects of L. major and L. ama-
zonensis upon the proinflammatory cytokines IL-17, IL-
1a and TNF-a, the primary Th1-inducing proinflamma-
tory cytokine, IL-12, and the Th2-associated cytokines
IL-4,-13, -6,-10 and IL-3 [20]. We also assayed for the
macrophage inflammatory chemokines macrophage
inflammatory protein 1a (MIP-1a) and monocyte che-
motactic protein-1 (MCP-1). We find that, although
LPS-induced IL-17 and IL-12 are repressed by both
Leishmania species, LPS-induced TNF-a and IL-1a
responses are enhanced. In addition, we determined that
both Leishmania species suppress LPS-induced IL-6, -13
and -3. Furthermore, L. amazonensis also suppressed
LPS-induced IL-4 and IL-10 whereas both Leishmania
species augmented LPS-induced MIP-1a and MCP-1
production. Our findings suggest, at least in the context
of TLR4 stimulation, that Leishmania promastigotes do
not promote generalized proinflammatory suppression
and instead appear to target specific cytokine signalling
pathways downstream of the TLR4 receptor, to selec-
tively modulate cytokine and chemokine production
during macrophage parasitization.
Methods
Isolation and Culture of Peritoneal Macrophages
Peritoneal cells were isolated by lavage from C57/BL6
mice that were purchased from The Jackson Laboratory
essentially as described previously [21], with the excep-
tion that RPMI-1640/10% FBS was used for peritoneal
lavage.
The peritoneal cells were stained with macrophage
markers F4/80, CD14, CD11b and CD 205 then analysed
by flow cytometry to confirm their macrophage pheno-
type and adjusted to a cell density of 4 × 10
5/ml.
Parasites
Promastigotes of L. major strain WHOM/IR/-/173 and
L. amazonensis strain IFLA/BR/67/PH8 (kindly provided
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tured in vitro at 27°C in medium 199 with 10% heat-
inactivated FBS as previously described [22]. Stationary
phase parasites were centrifuged at 1300 × g and resus-
pended in RPMI-1640 culture medium supplemented
with 10% FBS prior to addition to macrophage
monolayers.
Macrophage Treatment
0.8 ml aliquots of macrophages (4 × 10
5/ml) were incu-
bated for 2 hr on 4-well glass chamber slides, washed to
remove non-adherent cells, then co-incubated with or
without LPS (100 ng/ml), followed by the addition of
stationary phase promastigotes (20:1 parasite: macro-
phage), or 6 μm latex beads (Sigma) (20:1 bead: macro-
phage), as indicated in the Results. At 2, 8 or 19 hr
timepoints, 200 μl of culture supernatant was removed
and centrifuged to remove particulates prior to multi-
plex cytokine analysis.
Following removal of the 19 hr culture supernatants,
the macrophages were washed twice with PBS and
stained using Diff-Quik (DADE-Behring) as described
previously [22], evaluated microscopically (approxi-
mately 200 fields observed) and infection/uptake rates
determined to be 74%, 79% and 82% for L. major and L.
amazonensis, and latex beads respectively.
Multiplex cytokine analysis
Multiplex cytokine analyses that were performed using a
Bio-Plex kit (Bio-Rad) in accordance with manufac-
turer’s instructions and analysed using a Luminex
machine (Luminex Corporation).
ELISA assays
Duplicate culture supernatants were removed at the 19
hr timepoint and assayed for cytokine production using
ELISA kits from R&D systems, in accordance with man-
ufacturers’ instructions.
Results
Leishmania suppresses IL-17, IL-12 and IL-3 following
induction with LPS
Despite recent interest in IL-17, a key cytokine involved
in a variety immune responses, including the induction
of other cytokines, its production from macrophages in
the context of Leishmania infection has not been char-
acterized. We therefore investigated the release of IL-17
from macrophages during infection with Leishmania
alone, or during Leishmania infection in the presence of
LPS. Although incubation of macrophages with either L.
major or L. amazonensis alone did not induce IL-17
production, nor significant levels of any other cytokine
we assayed, stimulation with LPS alone caused signifi-
cant IL-17 induction compared to controls, as shown in
Figure 1A. However, co-incubation of the macrophages
with LPS in the presence of L. major or L. amazonensis
resulted in 7.1-fold and 13.1-fold suppression of IL-17,
respectively, relative to LPS alone (Figure 1A). To con-
firm that this suppression was not merely a consequence
of non-specific phagocytic uptake, we also analysed IL-
17 production from LPS in the presence of 6 μm latex
beads that were of comparable size to Leishmania.I n
contrast to incubation with LPS and Leishmania,c o -
incubation of LPS with latex beads caused less than
two-fold suppression compared to LPS alone (Figure
1A, white bars), indicating these effects were Leishma-
nia-specific. Since L. mexicana has previously been
shown to suppress LPS-induced IL-12 production [12],
we also analysed the macrophage LPS-induced IL-12
response in the presence of L. major and L. amazonen-
sis, or latex beads as a non-specific phagocytosis control.
As shown in Figure 1B, L. major and L. amazonensis
suppressed peak levels of LPS-induced IL-12 p40 subu-
nit 3.3-fold and 4.7-fold respectively, supporting pre-
vious findings [12]. In contrast, latex beads suppressed
IL-12p40 production only 1.4-fold. Since it is the IL-
12p70 heterodimer (IL-12p40/IL-12p35) that induces
Th1 responses, we also sought to compare its regulation
with IL-12p40. Although less striking than the down-
regulation of IL-12 p40, Leishmania amazonensis
mediated 2-fold down-regulation of LPS-induced IL-
12p70 at 19 hrs, whereas L. major and latex beads, both
showed modest suppression (Figure 1C). We also inves-
tigated the effects of Leishmania upon the induction of
IL-3 since IL-3 production may promote intracellular
survival because it has been associated with differentia-
tion of monocytes into macrophages that are less
responsive to IFNg than macrophages differentiated with
GM-CSF [23]. As shown in Figure 1D, whilst LPS
induced IL-3 levels significantly above the control treat-
ments, L. major and L. amazonensis suppressed LPS-
induced IL-3 2.5-fold and 3.4-fold respectively. In con-
trast, treatment with LPS and latex beads caused 1.4-
fold suppression, indicating that the IL-3 suppressive
effects of Leishmania were specific.
Leishmania suppresses the Th2-associated cytokines IL-4,
IL-6 and IL-13 following induction with LPS
Since susceptibility to Leishmania infection is generally
associated with a Th2 response in infected mice, we
investigated the effect of Leishmania on the ability of
LPS to induce the Th2 cytokines IL-4, IL-6, and IL-13
from macrophages, the primary cells parasitized by
Leishmania promastigotes. As shown in Figure 2A,
whilst LPS-induced production of IL-4 was significantly
upregulated by LPS alone (Figure 2A), peak production
of LPS-induced IL-4 was suppressed 2.3-fold by L. ama-
zonensis and 1.4-fold by latex beads, whereas negligible
suppression of LPS-inducedI L - 4w a so b s e r v e df o rL.
major (1.2-fold suppression). In the presence of L.
major, L. amazonensis and latex beads, LPS-induced IL-
6 responses were substantially abrogated, with 2.7-fold,
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induced significant levels of IL-13, L. major, L. amazo-
nensis and latex beads showed modest suppression,
down regulating LPS-induced IL-13 1.5 fold, 2-fold and
1.3-fold respectively (Figure 2B).
Leishmania augments release of IL-1a,T N F a and IL-10
following LPS induction
To determine if the suppressive effects of Leishmania
reflected a generalized counter-inflammatory response
against LPS-induced proinflammatory macrophage
cytokines, we also analysed the effect of Leishmania
uptake upon LPS-induction of the proinflammatory
cytokines IL-1a and TNFa.A ss h o w ni nF i g u r e3 A ,w e
found that, in contrast to its suppressive effects on IL-
17 and IL-12, L. major augmented LPS-induced IL-1a
1.6-fold. Conversely L. amazonensis had no effect on
LPS-induced IL-1a levels and latex beads showed a 1.7-
fold suppressive effect. In contrast to IL-1a,b o t hL.
major and L. amazonensis augmented LPS-induced
TNFa 1.8- and 1.9-fold, respectively at 8 hrs, the peak
Figure 1 Leishmania suppresses IL-17, IL-12 and IL-3 following induction with LPS. Cells were incubated with 100 ng/ml LPS with the
addition of L. major, L. amazonensis or latex beads at a parasite/bead: host cell ratio of 20:1 (indicated by blue, green and open bars,
respectively). At 2 hr, 8 hr and 19 hr timepoints, 200 μl of culture supernatant was removed, centrifuged to remove particulates and analysed for
cytokine expression by Bio-Plex assay as described in Methods. Media only, L. major alone, L. amazonensis alone, latex beads alone and LPS alone
(black, gray, purple, brown and red bars, respectively) were used as control treatments. Data represented are averages of two independent
replicate experiments, with error bars as indicated.
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data demonstrate that although Leishmania suppresses
certain LPS-induced proinflammatory cytokines, it can
simultaneously facilitate the production of other classical
inflammatory cytokines. Interestingly, L. amazonensis
generally showed a more suppressive effect than L.
major.
We also investigated the impact of Leishmania uptake
on LPS-induced IL-10, since this cytokine typically
antagonizes the biological effects of classic proinflamma-
tory cytokines such as IL-12. As shown in Figure 3C, at
8h rLeishmania augmented LPS-induced IL-10, how-
ever by 19 hrs, the peak of the LPS-induced IL-10
response, the levels of IL-10 were not significantly dif-
ferent between LPS alone and both Leishmania species.
In contrast, latex beads showed moderate suppression of
LPS-induced IL-10 at this timepoint.
Leishmania promotes the production of LPS-induced MIP-
1a and MCP-1
Since the chemokines macrophage inflammatory protein
(MIP)-1a and macrophage chemoattractant protein
(MCP)-1 have been shown to have an important role in
limiting macrophage parasitic burden [24] we sought to
determine whether Leishmania could suppress expres-
sion of these chemokines as a possible way to enhance
parasitization. As shown in Figure 4A, at the peak of the
LPS-induced response, L. major and L. amazonensis
promoted LPS-induced MIP-1a 1.7-fold and 1.6-fold
respectively, whereas latex beads had little effect. Analy-
sis of LPS-induced MCP-1 showed that L. major and L.
amazonensis dramatically augmented LPS-induced levels
of this chemokine, with 4.7-fold and 3.6-fold upregula-
tion respectively, whilst treatment of the LPS-induced
macrophages with latex beads showed no significant
impact on MCP-1 levels (Figure 4B). Both L. major and
L. amazonensis were also found to suppress LPS-
induced MIP-1b (data not shown).
Our findings were further validated by sampling cyto-
kine levels using ELISA assays, as shown for IL-17 (Fig-
ure 5; data not shown).
Discussion
Macrophages are key mediators of inflammatory
responses that are important for host immune protec-
tion against infectious challenge. When such responses
become dysregulated or chronically activated, however,
they contribute to the development of inflammatory dis-
eases such as atherosclerosis and arthritis. Although sig-
nificant advances, such as the identification of TLRs and
their associated intracellular signalling pathways, have
contributed substantially to our understanding of how
inflammatory responses are activated, critical gaps
remain in our understanding of how some microbes
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Figure 2 Leishmania suppresses the Th2-associated cytokines
IL-4, IL-6 and IL-13 following induction with LPS. Cells were
incubated with LPS (100 ng/ml) followed by the addition of L.
major, L. amazonensis or latex beads at a parasite/bead: host cell
ratio of 20:1 (denoted by blue, green and open bars, respectively).
At 2 hr, 8 hr and 19 hr timepoints, 200 μl of culture supernatant
was removed, centrifuged and analysed for cytokine expression by
Bio-Plex assay as described in Methods. Media only, L. major alone,
L. amazonensis alone, latex beads alone and LPS alone (black, gray,
purple, brown and red bars, respectively) were used as controls.
Data represented are averages of two independent replicate
experiments, with error bars as indicated.
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yote protozoan microbe that circumvents the classical
host innate immune response, and also actively sup-
presses macrophage responses to strong inflammatory
stimuli such as bacterial LPS [12,25-27]. These studies
have typically been limited to analyses of a relatively low
number of cytokines, and in general have not distin-
guished between the specific effects of Leishmania
uptake and non-specific effects of generalized phagocy-
tosis upon LPS-induced macrophage activation. We
sought to further explore the modulatory effects of
Leishmania upon LPS-induced macrophages by deter-
mining the specific effects of two clinically distinct spe-
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Figure 3 Leishmania augments release of IL-1a, TNFa and IL-10
following LPS induction. Cells were incubated with 100 ng/ml LPS
followed by L. major, L. amazonensis or latex beads at a parasite/
bead: host cell ratio of 20:1 (indicated by blue, green and open
bars, respectively). At 2 hr, 8 hr and 19 hr timepoints, culture
supernatants were removed, centrifuged then assayed for cytokine
expression by Bio-Plex assay as described in Methods. Media only, L.
major alone, L. amazonensis alone, latex beads alone and LPS alone
(black, gray, purple, brown and red bars, respectively) were used as
controls. Data represented are averages of two independent

























Figure 4 Leishmania promotes the production of LPS-induced
MIP-1a and MCP-1. Cells were incubated with 100 ng/ml LPS
followed by the addition of L. major, L. amazonensis or latex beads
at a parasite/bead: host cell ratio of 20:1 (indicated by blue, green
and open bars, respectively). At 2 hr, 8 hr and 19 hr timepoints, 200
μl of culture supernatant was removed, centrifuged then assayed for
cytokine expression by Bio-Plex assay as described in Methods.
Media only, L. major alone, L. amazonensis alone, latex beads alone
and LPS alone (black, gray, purple, brown and red bars, respectively)
were used as controls. Data represented are averages of two
independent replicate experiments, with error bars as indicated.
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by LPS-activated macrophages.
Consistent with previous observations, our studies
demonstrate that Leishmania efficiently evades robust
activation of many cytokines and chemokines. In the con-
text of LPS-induction, we found that the proinflammatory
cytokines IL-17, IL-12 and IL-3, and the Th2 cytokines IL-
4, IL-6 and IL-13 were all suppressed to varying degrees
by both L. major and L. amazonesis. For each of these
cytokines, the suppressive effects were more pronounced
with L. amazonensis than L. major. Although we cannot
rule out the possibility that the increased suppressive
effects we observed for L. amazonensis were due to their
marginally increased level of uptake compared to L. major,
we feel it is unlikely that such a subtle increase in parasite
uptake would lead to the striking increases in cytokine
suppression we observed.
Although the latex bead controls were moderately
suppressive at the peak of the LPS response, we found
that in general, Leishmania were significantly more so.
Another interesting finding of our study was that whilst
Leishmania suppressed some LPS-induced responses,
such as IL-4 and IL-13 at timepoints when the LPS
response was maximal (usually 19 hrs), these responses
were actually augmented by Leishmania at the 8 hr
timepoint. This observation is reminiscent of the refrac-
tory period observed with Toxoplasma gondii-induced
IL-12 production in dendritic cells [28], and may there-
fore not represent true suppression.
Although IL-17-producing Th17 cells have been the
subject of intensive study recently and IL-17 production
is critical for the expansion of innate immune cells, only
one report has described the importance of macro-
phage-derived IL-17 in inflammatory disease [7]. Indeed,
our study is the first to investigate the impact of Leish-
mania upon LPS-induced IL-17 production in macro-
phages. Our observations that both L. major and L.
amazonensis promastigotes strongly and specifically sup-
press LPS-induced IL-17 production, provide a new
model for studying mechanisms of IL-17 regulation.
Although we observed suppression of both IL-12p40
and IL-12p70, IL-12p40 suppression was more striking.
Interestingly, our finding that L. major and latex beads
had similar mildly suppressive effects suggests that pha-
gocytic uptake alone contributes significantly to suppres-
sion of LPS-induced IL-12p70 during L. major infection.
Our findings with L. amazonensis differ from those of
Cameron et al., [12], which showed its close relative, L.
mexicana, caused a more dramatic suppression of LPS-
induced IL-12p70. Instead, our data are more comparable
to previous findings with L. major-infected human
monocytes [29]. These different observations may be
attributable to distinct pathobiological properties known
to exist even amongst closely related Leishmania species.
L. major but not L. amazonensis showed augmentation
of LPS-induced IL-1a. Interestingly, IL-1a can promote
Th1 responses that ameliorate disease progression in sus-
ceptible BALB/c [30] whilst Th1-biased C57BL/6 mice
that are resistant to L. major remain susceptible to L. ama-
zonensis [15]. Whether or not the differences in macro-
phage responses elicited by L. amazonensis versus L.
major under our conditions contribute to the increased
severity of disease typically associated with L. amazonensis
compared to L. major, remains to be determined.
Production of IL-10 by Leishmania alone was not
strikingly increased above controls, however at 8 hrs
post treatment, both Leishmania species significantly
augmented LPS-induced levels of IL-10. Since IL-10
suppresses production of inflammatory cytokines, such
as IL-12, it is interesting that a classical proinflamma-
tory stimulus such as LPS also induces IL-10. Indeed,
these data are consistent with recent findings [31] and
may reflect IL-10-mediated negative feedback regulation.
Since IL-10 is a strong suppressor of host cytokine pro-
duction and promotes disease progression in leishmania-
sis [32,33], it is possible that the cytokine-suppressive
effects we observed could be attributable to Leishmania-
augmented IL-10 production. We feel this is unlikely
however, since although IL-10 is a potent suppressor of
macrophage TNF-a [34], the increased levels of IL-10
released by LPS/Leishmania in our study did not pre-
vent augmentation of TNFa production. Furthermore,
in contrast to both L. major and L. mexicana, absence
















Figure 5 ELISA analysis of Leishmania-mediated cytokine
suppression. Cells were incubated with LPS (100 ng/ml) followed
by L. major, L. amazonensis or latex beads at a parasite/bead to host
cell ratio of 20:1 (indicated by blue, green and open bars,
respectively). At 19 hrs, culture supernatants were taken, centrifuged
then assayed for IL-17 production by ELISA as described in Methods.
Media only, L. major alone, L. amazonensis alone, latex beads alone
and LPS alone (black, gray, purple, brown and red bars, respectively)
were used as controls. Data represented are averages of two
independent replicate experiments, with error bars as denoted.
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IL-10-independent immunomodulatory mechanisms.
Although these studies provide new insight into the
regulation of macrophage inflammatory responses by
Leishmania, it should be emphasized that they were per-
formed in vitro using peritoneal macrophages to identify
novel mechanisms of macrophage inflammatory modu-
lation. How these in vitro findings translate to in vivo
models of Leishmania infection has not yet been clari-
fied. It is possible, for example, that peritoneal macro-
phages may behave differently to the inflammatory
macrophages found at infection sites in the skin during
Leishmania inoculation. Further, the metacyclic-
enriched promastigote population inoculated during nat-
ural infection may have different effects upon macro-
phage responses than the less-defined heterogenous
population of stationary phase parasites used in our stu-
dies. It is also important to emphasize that Leishmania
amastigote stages may elicit different macrophage
responses than promastigotes. As such, future studies
with purified metacylic organisms and distinct macro-
phage populations will be helpful in determining the
extent to which our novel findings pertain to Leishma-
nia infection in vivo.
We also emphasize that studies of promastigote-
mediated modulation of LPS-induced cytokine responses
may have limited relevance in the context of natural
Leishmania infections, since Leishmania possesses no
known TLR4 agonists and there are no data confirming
that TLR4 agonists are introduced into the sandfly bite
site. Instead, however, these studies may be relevant for
the design of protective adjuvant-based vaccination stra-
tegies against Leishmania, using TLR agonists to pro-
mote optimal inflammatory cytokine profiles that may
facilitate sustained Th1 responses required for protective
immunity against this pathogen.
Conclusions
We have explored the cytokine-modulatory effects of
two clinically distinct species of Leishmania upon the
kinetics of a range of LPS-induced macrophage inflam-
matory responses. We find both suppression and pro-
motion of LPS-induced responses, indicating the
selective suppression and augmentation of specific cyto-
kine induction mechanisms. Our studies provide foun-
dations to pursue functional studies to further elucidate
the molecular mechanisms that underlie the distinct
cytokine responses to Leishmania that we observed.
Such investigations of Leishmania-mediated modulation
of host cytokine responses will advance our understand-
ing of inflammatory responses and likely promote new
avenues for therapeutic intervention against inflamma-
tory diseases.
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